Abstract

We sought to investigate the T1 kinetics of blood and myocardium after three infusion schemes of gadobenate dimeglumine (Gd-BOPTA) and subsequently compared contrastenhanced whole-heart coronary MRI after a bolus Gd-BOPTA infusion with nonenhanced coronary MRI at 1.5 T. Blood and myocardium T1 was measured in seven healthy adults, after each underwent three Gd-BOPTA infusion schemes (bolus: 0.2 mmol/kg at 2 mL/sec, hybrid: 0.1 mmol/kg at 2 mL/sec followed by 0.1 mmol/kg at 0.1 mL/sec, and slow: 0.2 mmol/ kg at 0.3 mL/sec). Fourteen additional subjects underwent contrast-enhanced coronary MRI with an inversion-recovery steady-state free precession sequence after bolus Gd-BOPTA infusion. Images were compared with nonenhanced T2-prepared steady-state free precision whole-heart coronary MRI in signal-to-noise ratio, contrast-to-noise ratio, depicted vessel length, vessel sharpness, and subjective image quality. Bolus and slow infusion schemes resulted in similar T1 during coronary MRI, whereas the hybrid infusion method yielded higher T1 values. A bolus infusion of Gd-BOPTA significantly improved signal-to-noise ratio, contrast-to-noise ratio, depicted coronary artery length, and subjective image quality, when all segments were collectively compared but not when compared segment by segment. In conclusion, whole-heart steady-state free precision coronary MRI at 1.5 T can benefit from a bolus infusion of 0.2 mmol/kg Gd-BOPTA. Magn Reson Med 000:000–000, 2010. V C 2010 Wiley-Liss, Inc.

Highlights

  • Abstracts of the 13th Annual SCMR Scientific Sessions - 2010 Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/files/pdf/1532-429X-11-S1-info

  • The potential benefits of contrast agents have been studied for coronary MRI; the contrast timing/injection rate and sequence remain to be optimized

  • We investigated three infusion schemes of gadobenate dimeglumine ([Gd-BOPTA]2, MultiHance; Bracco Imaging SpA, Milan, Italy), a high relaxivity extracellular contrast agent, for improved whole-heart coronary MRI by measuring blood T1 kinetics

Read more

Summary

Open Access

Peng Hu*1, Jonathan Chan, Jouke Smink, Beth Goddu, Kraig V Kissinger, Lois Goepfert, Warren J Manning and Reza Nezafat. Address: 1Beth Israel Deaconess Medical Center, Boston, MA, USA and 2Philips Healthcare, Best, Netherlands * Corresponding author from 13th Annual SCMR Scientific Sessions Phoenix, AZ, USA. Published: 21 January 2010 Journal of Cardiovascular Magnetic Resonance 2010, 12(Suppl 1):P51 doi:10.1186/1532-429X-12-S1-P51. Abstracts of the 13th Annual SCMR Scientific Sessions - 2010 Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/files/pdf/1532-429X-11-S1-info

Introduction
Methods
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.